What type of study is this?

This is a Human Clinical Trial study.

September 10, 2025Journal of Medical CasesOpen Access

Benralizumab in a Patient With Refractory Eosinophilic Endocarditis

View Full Paper

Ask AI

Bookmark

Authors

This case study demonstrates the impact of benralizumab on eosinophil counts in Loeffler's endocarditis, suggesting rapid intervention benefits.

Benralizumab normalized eosinophil counts within a week, stabilizing the patient’s cardiac condition.
An urgent mitral valve replacement was necessary due to eosinophil infiltration, complications from Loeffler's endocarditis.
Off-label use of benralizumab led to long-term stabilization of eosinophilic levels, preventing further cardiac injury.
Consideration for earlier use of benralizumab in managing Loeffler's endocarditis is indicated by the significant treatment response.

Schultz et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

This case study demonstrates the impact of benralizumab on eosinophil counts in Loeffler's endocarditis, suggesting rapid intervention benefits.